SCHEMBL1708745

SCHEMBL1708745

C/C(=C\c1ccccc1-c1ccc(O)cc1O)C(=O)NC(=N)N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
PPIA P62937 1/20 0.34
CHRNA7 P36544 1/20 0.33
CXCR1 P25024 1/20 0.33
MEN1 O00255 1/20 0.33
ALPL P05186 1/20 0.33
POLB P06746 1/20 0.33
ALPI P09923 1/20 0.33
ALPG P10696 1/20 0.33
KMT2A Q03164 1/20 0.33
EIF4H Q15056 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX5 P09917 2/20 0.33
TYR P14679 5/20 0.32
NR1H4 Q96RI1 1/20 0.32
PARP1 P09874 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
DHODH Q02127 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1277181 0.91 HSD17B1 (0.39) F10KDM4EMAPTMEN1POLB
SCHEMBL1277698 0.90 MAPT (0.36) F10KDM4EMAPTMEN1KMT2A
SCHEMBL1277440 0.90 ESR1 (0.34) F10DHODH
SCHEMBL1277263 0.90 DHODH (0.35) F10MAPTMEN1KMT2AABCG2
SCHEMBL1277277 0.85 BACE1 (0.40) F10ABCG2DHODHBACE1
SCHEMBL1277389 0.84 BAZ2B (0.38) F10BACE1
SCHEMBL1277133 0.84 F10 (0.37) F10DHODHBACE1
SCHEMBL1277150 0.83 DHODH (0.34) F10DHODH
SCHEMBL1277281 0.83 APP (0.43) F10KDM4EALOX5BACE1
SCHEMBL1277699 0.83 F10 (0.37) F10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088737-A2 NOVEL ACYL GUANIDINE DERIVATIVES AJINOMOTO CO., INC (JP) 2012-04-12 US disclosed
US-20120088737-A2 NOVEL ACYL GUANIDINE DERIVATIVES AJINOMOTO CO., INC (JP) 2012-04-12 US disclosed
US-20110082109-A1 NOVEL ACYL GUANIDINE DERIVATIVES AJINOMOTO CO., INC. (JP) 2011-04-07 US disclosed
US-20110082109-A1 NOVEL ACYL GUANIDINE DERIVATIVES AJINOMOTO CO., INC. (JP) 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082109-A1 NOVEL ACYL GUANIDINE DERIVATIVES SLC9A3, NHERF1, SLC9A2 F10 4727/4885KDM4E 1554/4885MAPT 3952/4885
US-20120088737-A2 NOVEL ACYL GUANIDINE DERIVATIVES SLC9A3, NHERF1, SLC9A2 F10 4727/4885KDM4E 1554/4885MAPT 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.